Ibiza has been the epicenter of the national debate on Alzheimer’s disease. The National and Ibero-American Congress held on the island concluded with the “Ibiza Declaration”, a document that demands the central government to urgently incorporate the new therapeutic treatments into the public health system, to guarantee equal access in all the autonomous communities.
As reported by IB3, during the event it was emphasized that these drugs, recently authorized by the European Medicines Agency, represent the most important advances in the last two decades. These are two treatments designed to be applied in the early stages of the disease, with the aim of slowing its progression and improving patients’ quality of life.
“It’s going to reach a very small audience at first, we think 5%, and with early diagnosis. It is an investment. When we attend an early diagnosis, we slow down the disease and we can stop it,” explained Mariló Almagro, president of the Spanish Confederation of Alzheimer’s and other Dementias (Ceafa).
Key meeting with Health
Ceafa has confirmed that on December 1 it will hold a meeting with the Ministry of Health to request that these new drugs be integrated into the National Health System as soon as possible, in order to guarantee universal and equitable access in all the autonomous communities.
The Confederation insists that there should be no territorial differences in access to therapies that represent a crucial opportunity for those living with this neurodegenerative disease.
The event, which was held last week, was described as multidisciplinary and was attended by patients, family members, healthcare professionals and third sector organizations. In addition, last Thursday Queen Sofia, who for years has been linked to the promotion of initiatives related to dementia, attended the event.
